Show simple item record

dc.contributor.authorMoullin, Joanna
dc.contributor.authorEhrhart, M.
dc.contributor.authorAarons, G.
dc.date.accessioned2018-12-13T09:09:59Z
dc.date.available2018-12-13T09:09:59Z
dc.date.created2018-12-12T02:47:09Z
dc.date.issued2018
dc.identifier.citationMoullin, J. and Ehrhart, M. and Aarons, G. 2018. Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory. Implementation Science. 13: 89.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/71411
dc.identifier.doi10.1186/s13012-018-0782-1
dc.description.abstract

© 2018 The Author(s). Background: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinicians or providers at the individual level to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for the development and testing of pragmatic measures of providers' intentions to use a specific innovation or evidence-based practice (EBP). Methods: Nine items were developed to assess providers' intentions to use a specific innovation or EBP. Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179 providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA. Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch model, the response scale used, individual item fit, differential item functioning (DIF), and person separation. Results: Following a stepwise process, the scale was reduced from nine items to three items to increase the feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item unidimensional scale showed good person separation (PSI =.872), no disordering of thresholds, and no evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of implementation intentions. Conclusions: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers' intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic implementation measures.

dc.publisherBioMed Central Ltd.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleDevelopment and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
dc.typeJournal Article
dcterms.source.volume13
dcterms.source.number1
dcterms.source.issn1748-5908
dcterms.source.titleImplementation Science
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/